Anatomics Pty Ltd

Banner Image

Pictured: Paul D'Urso of Anatomics, MTPConnect Chair Sue MacLeman and MTAA CEO Ian Burgess in April 2018 at the launch of BioMedTech Horizons in Melbourne. 

Project title: 3D printing and the manufacture of 'PoreStar' - a novel porous polyethylene implant material 

In 2014, Anatomics, in conjunction with CSIRO and Australian universities, developed a breakthrough porous high-density polyethylene implant material, PoreStar. 

PoreStar's material advantages include its superior tensile and flexural strength avoiding cracks when bent, the ability to use fixation screws very close to the implant margins without material breakage, and a unique scaffold architecture that facilitates tissue ingrowth. This project aims to advance the state-of-the-art in pHDPE craniomaxillofacial (CMF) implant manufacturing, leveraging 3D printing to reduce process complexity, product turnaround time and cost of goods. Moreover, the project seeks to improve surgical practice by extending the use of temporary implants to patient-specific CMF surgeries, and develop improved software solutions for surgical planning and preoperative estimation of cosmesis, aiming to reduce complications and reoperation rates for CMF surgeries.

BMTH Round: One 

State: Victoria


  • MTPConnect Grant: $891,500
  • Industry Contribution: $1,047,446

Duration: May 2018 - June 2020

Outcomes: Anatomics successfully Finished all activities for this project in June 2020 and fully realised their original aim of developing high-end 3D printing and software to enable the efficient and scalable production of StarPore craniofacial implants. This included opening a new production facility, commissioning a SLS 3D printer and introducing an in-house, ISO 13485 certified sterilisation process.

Visit Anatomics to learn more.

Twitter: @anatomicsrx

LinkedIn: Anatomics

Contact: Gibran Maher, Vice President of Global Sales and Marketing